- +1 551 333 1547
- +44 2070 979277
- live:skype_chat
Latest Edition Released on Pediatric Growth Hormones Market
Pediatric Growth Hormones Market Latest Edition Published with Forecast to 2027- Apr 27, 2021
- Pharmaceuticals
In Jan 2021, Pfizer Inc. and OPKO Health Inc. announced that the US Food and Drug Administration (FDA) has accepted for filing the initial Biologics License Application (BLA) for somatrogon, a long-acting human growth hormone that is intended to be administered once-weekly for the treatment of pediatric patients with growth hormone deficiency (GHD).
The article cited AMA's "Global Pediatric Growth Hormones Market Study" explored CAGR of %. According to the report, Rising Clinical Trial and Product Development Activities is one of the primary growth factors for the market. Growing Number of Endocrine Disorders
is also expected to contribute significantly to the Pediatric Growth Hormones market. Overall, applications of Pediatric Growth Hormones, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The Route of Administration, such as Intravenous, is boosting the Pediatric Growth Hormones market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Indication, such as Growth Hormone Deficiency, is boosting the Pediatric Growth Hormones market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Distribution Channel, such as Hospital Pharmacies, is boosting the Pediatric Growth Hormones market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
AMA’s Analyst on the Global Pediatric Growth Hormones market identified that the demand is rising in many different parts of the world as "Increasing Pediatric Diagnostic Campaigns and Programs in Developing Countries ". Furthermore, some recent industry insights like "In Oct 2020, Pfizer Inc. and OPKO Health Inc. announced that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating somatrogon dosed once-weekly in children 3 to <18 years of age with growth hormone deficiency (GHD), met its primary endpoint of improved treatment burden compared to GENOTROPIN® (somatropin) for injection administered once-daily., and In May 2019, Ascendis Pharma A/S announced preliminary results from the phase 3 fliGHt Trial of TransCon Growth Hormone (hGH). The results indicated treatment with TransCon hGH was safe and well-tolerated in subjects with pediatric growth hormone deficiency (GHD) who were previously treated with commercially available daily growth hormone therapies" is constantly making the industry dynamic.
The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Pediatric Growth Hormones market according to Type, Application, and regions
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key drivers & trends of the market
**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 currency rates.
Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Pediatric Growth Hormones market and other related sub-markets covered in the study.
o Key & emerging players in the market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Have a look at detailed Table of Content for Pediatric Growth Hormones Market Study
Data Triangulation
The overall Pediatric Growth Hormones market size is calculated using market estimation process, the Pediatric Growth Hormones market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Pediatric Growth Hormones market size has been validated using both top-down and bottom-up approaches.
AMA’s Analyst on the Global Pediatric Growth Hormones market identified that the demand is rising in many different parts of the world as "Increasing Pediatric Diagnostic Campaigns and Programs in Developing Countries ". Furthermore, some recent industry insights like "In Oct 2020, Pfizer Inc. and OPKO Health Inc. announced that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating somatrogon dosed once-weekly in children 3 to <18 years of age with growth hormone deficiency (GHD), met its primary endpoint of improved treatment burden compared to GENOTROPIN® (somatropin) for injection administered once-daily., and In May 2019, Ascendis Pharma A/S announced preliminary results from the phase 3 fliGHt Trial of TransCon Growth Hormone (hGH). The results indicated treatment with TransCon hGH was safe and well-tolerated in subjects with pediatric growth hormone deficiency (GHD) who were previously treated with commercially available daily growth hormone therapies" is constantly making the industry dynamic.
The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Pediatric Growth Hormones market according to Type, Application, and regions
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key drivers & trends of the market
**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 currency rates.
Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Pediatric Growth Hormones market and other related sub-markets covered in the study.
o Key & emerging players in the market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Have a look at detailed Table of Content for Pediatric Growth Hormones Market Study
Data Triangulation
The overall Pediatric Growth Hormones market size is calculated using market estimation process, the Pediatric Growth Hormones market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Pediatric Growth Hormones market size has been validated using both top-down and bottom-up approaches.
Craig Francis
PR & Marketing Manager